AU2001292730A1 - Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists - Google Patents
Substituted imidazoles as dual histamine h1 and h3 agonists or antgonistsInfo
- Publication number
- AU2001292730A1 AU2001292730A1 AU2001292730A AU9273001A AU2001292730A1 AU 2001292730 A1 AU2001292730 A1 AU 2001292730A1 AU 2001292730 A AU2001292730 A AU 2001292730A AU 9273001 A AU9273001 A AU 9273001A AU 2001292730 A1 AU2001292730 A1 AU 2001292730A1
- Authority
- AU
- Australia
- Prior art keywords
- antgonists
- agonists
- substituted imidazoles
- dual histamine
- histamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23405300P | 2000-09-20 | 2000-09-20 | |
US60/234,053 | 2000-09-20 | ||
PCT/US2001/029095 WO2002024659A2 (en) | 2000-09-20 | 2001-09-18 | Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292730A1 true AU2001292730A1 (en) | 2002-04-02 |
Family
ID=22879692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292730A Abandoned AU2001292730A1 (en) | 2000-09-20 | 2001-09-18 | Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists |
Country Status (15)
Country | Link |
---|---|
US (1) | US6506756B2 (en) |
EP (1) | EP1318994B1 (en) |
JP (1) | JP2004509871A (en) |
CN (1) | CN1461303A (en) |
AR (1) | AR030946A1 (en) |
AT (1) | ATE387439T1 (en) |
AU (1) | AU2001292730A1 (en) |
CA (1) | CA2421826C (en) |
DE (1) | DE60133014T2 (en) |
ES (1) | ES2300364T3 (en) |
HK (1) | HK1052179A1 (en) |
MX (1) | MXPA03002448A (en) |
MY (1) | MY117975A (en) |
TW (1) | TW589303B (en) |
WO (1) | WO2002024659A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6607862B2 (en) | 2001-08-24 | 2003-08-19 | Intel Corporation | Damascene extreme ultraviolet lithography alternative phase shift photomask and method of making |
JP4384918B2 (en) * | 2002-04-18 | 2009-12-16 | シェーリング コーポレイション | (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
EP1494671B1 (en) | 2002-04-18 | 2011-10-19 | Schering Corporation | 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
US7105505B2 (en) | 2002-04-18 | 2006-09-12 | Schering Corporation | Benzimidazole derivatives useful as histamine H3 antagonists |
NL1026634C2 (en) * | 2004-07-12 | 2006-01-16 | Willem Jacob Van Der Burg | Psychopharmaceutical preparation and active ingredient. |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
US9224955B1 (en) * | 2014-10-31 | 2015-12-29 | Feng-wen Yen | Purifying method for organic optoelectronic material |
CN113880808A (en) * | 2020-07-03 | 2022-01-04 | 合肥医工医药股份有限公司 | Triazole compounds, preparation method and medical application thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2586562B1 (en) | 1985-09-02 | 1989-03-10 | Inst Nat Sante Rech Med | PHARMACEUTICAL COMPOSITION CONTAINING A-METHYLHISTAMINE |
EP0411048A1 (en) | 1988-04-28 | 1991-02-06 | Schering Corporation | Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use |
GB8916947D0 (en) | 1989-07-25 | 1989-09-13 | Smith Kline French Lab | Medicaments |
ES2058651T3 (en) | 1990-03-30 | 1994-11-01 | Heumann Pharma Gmbh & Co | USE OF GUANIDINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICINE WITH ANTAGONIST ACTIVITY OF NPY. |
GB9115740D0 (en) | 1991-07-20 | 1991-09-04 | Smithkline Beecham Plc | Medicaments |
JP2540015B2 (en) | 1991-12-18 | 1996-10-02 | シェリング・コーポレーション | Histamine H 2) Imidazolyl-alkyl-piperazine and -diazepine derivatives as agonists / antagonists |
US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
ATE234290T1 (en) | 1993-11-15 | 2003-03-15 | Schering Corp | PHENYLALKYL-IMIDAZOLE AS H3 RECEPTOR ANTAGONISTS |
FR2732017B1 (en) | 1995-03-21 | 2000-09-22 | Inst Nat Sante Rech Med | NOVEL IMIDAZOLE DERIVATIVES AND / OR HISTAMINE H3 RECEPTOR AGONISTS AND / OR AGONISTS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS |
JP2002515912A (en) | 1997-06-24 | 2002-05-28 | ノボ ノルディスク アクティーゼルスカブ | Use of somatostatin agonists and antagonists for the treatment of eye-related diseases |
US5869479A (en) | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
AU4387699A (en) | 1998-07-24 | 2000-02-14 | Russinsky Limited | A process for preparing benzocycloheptapyridin-11-ones |
-
2001
- 2001-09-18 AU AU2001292730A patent/AU2001292730A1/en not_active Abandoned
- 2001-09-18 AT AT01973119T patent/ATE387439T1/en not_active IP Right Cessation
- 2001-09-18 WO PCT/US2001/029095 patent/WO2002024659A2/en active IP Right Grant
- 2001-09-18 JP JP2002529071A patent/JP2004509871A/en not_active Withdrawn
- 2001-09-18 ES ES01973119T patent/ES2300364T3/en not_active Expired - Lifetime
- 2001-09-18 DE DE60133014T patent/DE60133014T2/en not_active Expired - Lifetime
- 2001-09-18 MY MYPI20014365A patent/MY117975A/en unknown
- 2001-09-18 CN CN01815978A patent/CN1461303A/en active Pending
- 2001-09-18 AR ARP010104399A patent/AR030946A1/en unknown
- 2001-09-18 EP EP01973119A patent/EP1318994B1/en not_active Expired - Lifetime
- 2001-09-18 MX MXPA03002448A patent/MXPA03002448A/en active IP Right Grant
- 2001-09-18 US US09/954,867 patent/US6506756B2/en not_active Expired - Fee Related
- 2001-09-18 CA CA002421826A patent/CA2421826C/en not_active Expired - Fee Related
- 2001-09-19 TW TW090123001A patent/TW589303B/en not_active IP Right Cessation
-
2003
- 2003-06-20 HK HK03104436.1A patent/HK1052179A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA03002448A (en) | 2003-06-19 |
DE60133014T2 (en) | 2009-02-26 |
CA2421826C (en) | 2009-10-27 |
MY117975A (en) | 2004-08-30 |
US20020086859A1 (en) | 2002-07-04 |
CN1461303A (en) | 2003-12-10 |
CA2421826A1 (en) | 2002-03-28 |
EP1318994A2 (en) | 2003-06-18 |
HK1052179A1 (en) | 2003-09-05 |
WO2002024659A2 (en) | 2002-03-28 |
AR030946A1 (en) | 2003-09-03 |
ES2300364T3 (en) | 2008-06-16 |
EP1318994B1 (en) | 2008-02-27 |
JP2004509871A (en) | 2004-04-02 |
ATE387439T1 (en) | 2008-03-15 |
WO2002024659A3 (en) | 2002-10-24 |
TW589303B (en) | 2004-06-01 |
DE60133014D1 (en) | 2008-04-10 |
US6506756B2 (en) | 2003-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3956900A (en) | Substituted imidazoles, their preparation and use | |
AU2001256769A1 (en) | Triazole derivatives | |
AU2001234128A1 (en) | Novel imidazoline compounds | |
MXPA03000939A (en) | Imidazole derivatives. | |
AU2002336273A1 (en) | Heterocyclic compounds and their use as histamine h4 ligands. | |
AU3033100A (en) | Substituted imidazoles, their preparation and use | |
AU2002334881A1 (en) | Composite guidewire | |
AU4815500A (en) | Shared views for browsing content | |
AU4882101A (en) | Mmp-12 inhibitors | |
MXPA03006773A (en) | Imidazole derivatives. | |
AU2001267766A1 (en) | Pyrazole derivatives | |
MXPA03006484A (en) | Imidazolyl derivatives as corticotropin releasing factor inhibitors. | |
AU2002214163A1 (en) | Pyridyl-substituted triazoles as tgf inhibitors | |
AU2000223275A1 (en) | Novel triazole derivatives | |
AU2001280590A1 (en) | 5-substituted 2-aryl-4-pyrimidinones | |
AU2001258563A1 (en) | Chromatic-dispersion compensator | |
AU2002241459A1 (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
AU2001292730A1 (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists | |
AU5338699A (en) | Imidazoles and related compounds as alpha1a agonists | |
AU2001291040A1 (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
AU2001292723A1 (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
AU2001276354A1 (en) | Hetaryl-substituted heterocycles | |
AU6170700A (en) | Stopper rod | |
AU2001278360A1 (en) | Wood-duroplastic composites | |
AU2001231107A1 (en) | Improved lactational |